We make several transfection reagents for primary cells, and they differ based on the nature of the cells (i.e. cancerous or non-cancerous). For primary neurons, effective lipofection approaches can get to 70% efficiency in cancerous cells (https://altogen.com/product/neuro-2a-transfection-reagent-neuroblastoma-cells-ccl131/) and likely lower efficiencies using generic reagents in non-cancerous cells (https://altogen.com/product/altofect-transfection-reagent/). If your cells are not dividing quickly, transfection efficiencies will be much lower than that for established and fast-proliferating cell lines.
Look at Mirus. They have several transfection reagents and one specific for neural type cells. https://www.mirusbio.com/products/transfection/transit-neural-transfection-reagent
We make several transfection reagents for primary cells, and they differ based on the nature of the cells (i.e. cancerous or non-cancerous). For primary neurons, effective lipofection approaches can get to 70% efficiency in cancerous cells (https://altogen.com/product/neuro-2a-transfection-reagent-neuroblastoma-cells-ccl131/) and likely lower efficiencies using generic reagents in non-cancerous cells (https://altogen.com/product/altofect-transfection-reagent/). If your cells are not dividing quickly, transfection efficiencies will be much lower than that for established and fast-proliferating cell lines.